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Abstract. A rif mutant of Escherichia coli that exhibits medium and temperature-dependent
sensitivity to rifampicin is described. In the absence of rifampicin, this strain grows in minimal
and rich media at 30°C and 42°C. In its presence it is viable in rich medium at both
temperatures, but in minimal medium only at 30°C. In minimal-rifampicin medium at the
higher temperature, RNA synthesis is decreased. The addition of certain divalent salts
(MgSO4, CaCl2, BaCl2) in excess, or chelators (EDTA, EGTA, o-phenanthrolein) greatly
increase viability in minimal-rifampicin medium at 42°C. Excess MgSO4 (10 mM) also
increases the rate of RNA synthesis in the same medium. A model is proposed wherein the rif
mutation is suggested to cause a structural change in RNA polymerase that allows the binding
of rifampicin and other ligands at 42°C. Rifampicin-binding is suggested to alter the 
conformation of RNA polymerase, impairing its ability to express genes required for growth in 
minimal medium. Implicit in this view is the assumption that these genes are structurally 
different from those expressed in rich medium in respect of certain template features 
recognized by RNA polymerase.
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Introduction 
 
Earlier reports from our laboratory described the isolation, genetic mapping and 
physiological characterisation of a temperature-sensitive transcription mutant of 
Escherichia coli in which the mutation mapped at a locus different from the loci coding 
for the subunits of RNA polymerase (Jabbar and Jayaraman, 1976,1978; Jabbar, 1979; 
Jayaraman and Jabbar, 1980). It was suggested that the product of the locus could be an
accessory transcription factor. In an attempt to obtain genetic evidence in support of
this notion Dass and Jayaraman (1985) isolated a rifampicin-resistant (rif), 
temperature-insensitive derivative from a mutant which originally harboured the 
temperature-sensitive mutation. Genetic analysis of this derivative (Dass and 
Jayaraman, 1985) showed (i) the rif mutation was not responsible for the temperature-
insensitive phenotype of this derivative and (ii) a second mutation mapping in the same 
gene suppressed the ts phenotype of the original mutation. The second mutation, by 
itself, conferred temperature-sensitivity and caused defects in [3H]-uridine incorpor-
ation into RNA (Dass and Jayaraman, 1985). Dass and Jayaraman (1985) mapped the 
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locus precisely in relation to other markers in the vicinity and also called the locus fit 
(factor involved in transcription). The present report describes some properties of the
rif mutation present in the temperature-insensitive derivative. The results suggest that 
this mutation leads to changes in transcription specificity under certain conditions.
 
Materials and methods 
 
Media and chemicals 
 
MA minimal medium and LB nutrient medium were used for all experiments (Miller, 
1972). Additional salts were used at the indicated concentrations. Chelators were added 
at 0·1 mM, and rifampicin at 100 µg/ml. Rifampicin and o-phenanthrolein were from 
Sigma Chemical Co., St. Louis, Missouri, USA, while all other chemicals were from 
local sources. [3H]-Uridine was from Bhabha Atomic Research Centre, Bombay. 
 
Bacterial strains 
 
The bacterial strains used in this study are listed in table 1. 
 
 
 
Table 1. List of E. coli strains used in this work.
 
 
 
 
Methods 
 
P1 transductions were done as described by Miller (1972). For studying RNA synthesis, 
cells were grown to mid-log phase at 42°C in minimal medium, with or without 
rifampicin. Cultures were adjusted to the same turbidity and labelled with [3H]- 
uridine (12·7 Ci/mmol; 1 µ Ci/ml). At intervals, during a period of 30 min, samples were 
treated with ice-cold 10 % trichloroacetic acid containing 100 µ g/ml uridine, filtered on 
membrane filters, washed and counted in a Beckman Liquid Scintillation Counter. 
Incorporation was linear with time. 
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Results 
 
Mapping of the rif  mutation in BJ240 
 
This paper describes the properties of the rif  mutation present in the strain BJ240 
described earlier (Dass and Jayaraman, 1985). First of all, it was necessary to ensure that 
this mutation maps at the rpoB locus (90 min; Bachmann, 1983) as almost all rif. 
mutations do (Yura and Ishihama, 1979). Data presented in table 2 show that the rif 
mutation in BJ240 is cotransducible with argE or metA at approximately the same 
frequency (50 %) which would be expected of mutations in the rpoB locus. It can 
therefore be concluded that the rif  mutation under study lies in rpoB. Accordingly it was 
designated as rpoB240. 
 
 
Table 2.  Transductional mapping of the rif mutation in BJ240. 
 
 
rif—Resistance to rifampicin. 
rif+ —Sensitivity to rifampicin. 
 
 
Viability of ΒJ 5702 
 
The rpoB240 mutation was transduced into an rpoB+ strain, CSH57. The resultant
transductant, BJ5702, was used for the studies described below. Viability of BJ5702
under different conditions was compared with that of its parent (CSH57) and BJ5701 (a 
spontaneous rif mutant of CSH57). It can be seen from table 3 that in the absence of
rifampicin, BJ5702 behaves just like CSH57 and BJ5701. In LB-rifampicin medium, 
BJ5702 was fully viable at 30°C and 42°C. In minimal-rifampicin medium, however, 
 
 
Table 3.  Viable colony counts of the strains in the presence and absence of rifampicin at 30°C and 42°C 
in LB and minimal media. 
 
Viable counts were normalized to the number (taken as 100) on rifampicin-free minimal plates at 30°. 
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colony forming ability at 30°C was not affected but viability at 42°C dropped 
drastically. The few colonies that appeared at the higher temperature (at a frequency of 
approximately 5 × 10–4) continued to be similarly non-viable on subsequent plating on 
minimal-rifampicin plates at 42°C (data not shown). There is thus a medium and 
temperature-dependent switch in the phenotype of BJ5702 from rifampicin resistance
to sensitivity. 
 
RNA synthesis in BJ5702 
 
Is the non-viability of BJ5702 under the above conditions a reflection of the sensitivity 
of transcription to rifampicin? When a culture of the mutant was inoculated in 
minimal-rifampicin medium at 42°C to an initial density of about 107 cells/ml (as is 
usually done), the culture grew as well as it did in the absence of rifampicin (data not 
shown). This was in seeming contradiction to the results presented above. In liquid 
medium, under the usual culture conditions, cells undergo not more than 9 divisions 
before cessation of growth. On the other hand, a colony on a plate arises from a single 
cell and is the result ofat least 24 cell divisions. It was therefore decided to increase the 
duration of growth of BJ5702 in liquid medium such as to mimic growth conditions on 
plates. The strain was subcultured in rifampicin-minimal medium at 42°C to an initial 
cell density of 5 × 102 cells/ml. The culture did grow, but at a decreased rate and ceased 
growth at a smaller cell density, relative to the control (no rifampicin; data not shown). 
It is not clear how cells that are largely non-viable on plates can grow in liquid medium. 
A possible explanation is that initially cells grow normally at 42°C. With increasing time 
of exposure to rifampicin they slacken in their growth rate and ultimately cease to 
grow altogether, but nonetheless, allowing a small random population to escape the 
inhibitory action of the antibiotic.
[3H]-Uridine incorporation was studied in cultures grown at 42°C from an initial
density of 107 cells/ml. There was no difference in incorporation in the presence or 
absence of rifampicin (table 4). Thus under the usual experimental conditions, RNA 
synthesis in BJ5702 is resistant to inhibition by rifampicin. This result (coupled with the 
fact that BJ5702 is viable on LB-rifampicin plates) almost certainly demonstrates that 
RNA polymerase in this strain is a rifampicin-resistant enzyme. [Under the same 
conditions, the rpoB+ enzyme of the wild-type strain CSH57 is sensitive to rifampicin 
(table 4)]. BJ5702 was next grown from an initial density of about 5 × 102 cells/ml. In 
the culture grown in the presence of rifampicin, incorporation was considerably less 
(table 4). An implicit assumption in correlating [3H]-uridine incorporation and
 
 
Table 4. Incorporation of [3H]-uridine at 42°C in cultures grown from different
initial densities in the presence and absence of rifampicin. 
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viability is that incorporation represents all the species of RNA needed for growth
under a given set of conditions. This need not necessarily be true with BJ5702 labelled at 
42°C in the presence of rifampicin. There could be qualitative differences between RNA 
synthesized in minimal medium at 42°C in the presence and absence of the antibiotic. 
Such differences will not show up markedly in labelling experiments, but could be seen 
as loss of viability. Colony forming ability is therefore a more reliable index of 
rifampicin-sensitivity/resistance than the rate of [3H] -uridine incorporation.
 
Effect of  cations on rifampicin-sensitivity 
 
Is BJ5702 'conditionally auxotrophic' in minimal-rifampicin medium at 42°C? 
Addition of various amino acids in different combinations failed to reverse the 
phenotype of this strain (data not shown). We also wondered if changes in the 
composition or concentration of media components could reverse its phenotype to 
rifampicin-resistance. During the course of experiments designed to test this view, it 
was observed that the addition of excess MgSO4 to minimal-rifampicin medium 
increased the viability of BJ5702. This observation was followed up by studying the 
effect of a number of divalent cations. These were: Zn2+ (an innate constituent of RNA 
polymerase); Mg2+ (essential for the activity of RNA polymerase); Mn2+ (which can 
substitute for Mg2+ in certain transcription reactions); Ca2+ (a physiologically
important ion) and Ba2+ (a randomly chosen ion). Salts of these divalent cations were 
added to minimal-rifampicin medium at 42°C to test their effect on the viability of 
BJ5702. It is apparent from table 5 that while Zn S O4 had no effect and MnCl2 a partial 
effect, MgSO4, BaCl2 and CaCl2 greatly reversed the rifampicin-sensitivity of this 
strain. 
 
 
Table 5.  Effect of divalent salts on the viability of BJ5702 in minimal medium at 42°C with and without 
rifampicin. 
 
Colony counts normalized to the number (taken as l00) on plates without added salt and rifampicin. 
N. D. —Not determined. 
 
 
 
One possibility was that excess of salts/ions in the medium limited the effective
concentration of rifampicin per cell, perhaps by complexing with the antibiotic, or by
altering the permeability of cells to rifampicin. If this were true, a wild type (rpoB+)
strain should be less sensitive to rifampicin when MgSO4 is added in excess. However, 
218 Dass and Jayaraman 
 
the viability of CSH57 was inhibited by rifampicin to the same extent irrespective of the
addition of 10 mM MgSO4 (data not shown).
The possible effect of excess MgSO4 on RNA synthesis in BJ5702 was studied. Cells
were grown at 42°C, starting from an initial density of about 5 × 102 cells/ml. The
culture grown in the presence of rifampicin and 10 mM MgSO4 incorporated more 
[3H]-uridine (1·5 fold) than the culture grown in rifampicin, but without excess 
MgSO4. Thus the ability of BJ5702 to grow on rifampicin-plates in the presence of 
MgSO4 can be accounted for, at least in part, by a positive effect of Mg2+ on 
transcription. In line with the conclusions drawn earlier, Mg2+ (and possibly other
divalent cations) perhaps delays or prevents an eventual transition of cells to 
rifampicin-sensitivity in minimal medium at 42°C, allowing for a greater fraction to 
undergo sufficient divisions and foram colonies.
 
Influence of chelators on viability of ΒJ5702 
 
If divalent cations can reverse the phenotype of BJ5702 to rifampicin-resistance, would
the addition of ion-chelators increase the sensitivity of this strain? Three commonly 
used chelators were chosen, namely, EDTA, EGTA and o-phenanthrolein. These were 
added to minimal-rifampicin medium at a non-lethal concentration of 0·1 mM. All the 
3 chelators greatly restored the viability of BJ5702 in minimal-rifampicin medium at
42°C (table 6). 
 
 
Table 6. Influence of chelators on the viability of BJ5702 in minimal-rifampicin medium at 42°C.
 
Normalized to the number (taken as 100) on plates without added chelator and rifampicin.
Chelators were added to a final concentration of 0·1 mM.
 
 
Discussion 
 
We have described in this paper some properties of a strain harbouring a particular rif 
mutation, rpoB240. This mutant is conditionally sensitive to rifampicin, depending on 
the medium, temperature, and the presence/absence of (excess) divalent cations, or 
metal chelators. Such behaviour can be partially correlated with the pattern of RNA 
synthesis. Our results can be rationalized by proposing specific conformational changes 
in the rpoB240 RNA polymerase as a result of temperature, and the binding rifampicin, 
ions, or chelators to the enzyme. There is extensive evidence to suggest that the 
conformation of RNA polymerase is of crucial importance in transcription (Travers et 
al., 1981). Mutations in the rpoB (rif) gene affect promotor selection and termination
(Yura and Ishihama, 1979), possibly by altering the conformation of the polymerase
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(Ovchinnikov et al., 1983). Conformational changes in the enzyme attendant on
rifampicin binding have been proposed to be of importance in its activity (Krakow et 
al., 1976; Nakamura and Yura, 1976; Doi, 1977; Reisbig et al., 1982). Current evidence 
suggests that rifampicin may bind to RNA polymerase from rif mutants also. Some of 
these mutants are sensitive to derivatives of the anitibiotic. These derivatives act on the 
rif Polymerase by a mechanism similar to that of rifampicin on the wild-type enzyme, 
possibly through interaction with the same enzyme site (Nikiforov et al., 1982). Metal 
ions like Mg2+ and Mn2+ bind to the substrate-binding site (Goldthwait et al., 1970) 
located in the ß-subunit (Armstrong et al., 1976) and bring about structural changes in
the enzyme (Krakow et al., 1976). A Co2+-containing RNA polymerase shows 
alterations in promotor recognition properties with T7 and λ plac5 templates 
(Speckhard et al., 1977). Various lines of evidence, including enzyme reconstitution 
studies, suggest that Zn2+ in RNA polymerase could be involved in maintaining a
required conformation (Krakow et al., 1976; Zillig et al., 1976). Chelators like o-
phenanthrolein and picolinic acid are believed to inhibit transcription (specifically at
the initiation step) by forming a ternary complex with zinc in RNA polymerase 
(Scrutton et al., 1971; Speckhard et al., 1977; Collins et al., 1979). During a period of 
transient growth inhibition by chelators, it has been proposed that the proteins 
synthesized are quantitatively and qualitatively different from those made during 
normal growth (Collins et al., 1979).
We propose a model that may be quite consistent with the above reports. The
rpoB240 mutation is suggested to cause a change in RNA polymerase such that it is 
conformationally altered, but not functionally inactivated, at the higher temperature. 
Such altered topology allows the binding of rifampicin and other ligands like metal ions 
and chelators to the enzyme. The rifampicin-bound polymerase is affected in 
transcription specificity such that it fails to express at 42°C the genes required for 
growth in minimal medium. Metal ions and chelators possibly revert the conformation 
of the polymerase-rifampicin complex to one that can express these genes.
An implicit assumption of this model is that genes expressed in minimal medium and
those expressed in rich medium are not only functionally different (anabolic versus 
catabolic), but also structurally so. The selective transcription of genes has been partly 
attributed to the extent of supercoiling of different regions of the chromosome (Smith, 
1981). The number of such supertwisted template domains and their degree of coiling 
may depend on, among other things, the medium of growth (Worcel and Burgi, 1972; 
Sinden and Pettijohn, 1981). The amino acid biosynthetic operons have characteristic 
structural features that ensure optimal expression in minimal medium and attenuation
in rich medium (Kolter and Yanofski, 1982). Several catabolite sensitive operons have a 
special promotor sequence recognized by the CAMP-CAP complex (Rosenberg and 
Court, 1979). A number of operons stringently regulated under amino acid starvation 
have a sequence called the 'discriminator' that sets them apart from other genes 
(Travers et al., 1981). 
It is possible that the 'minimal medium genes' differ from the 'LB medium genes' in
respect of certain template features (sequences, degree of coiling etc.) recognized by 
RNA polymerase. On the other hand, failure of the rpoB240 polymerase-rifampicin 
complex to express just a few genes (as opposed to a whole group or class of genes) in 
minimal medium could well lead to non-viability. Rif mutants that do not grow as a 
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result of inability to express one or more genes required for the biosynthesis of any one
amino acid have been reported (Morishita and Yura, 1976; Ryu and Takayanagi, 1979).
However, this is not likely to be the case with BJ5702 since the addition of different 
amino acids to minimal-rifampicin medium at 42°C did not restore colony forming 
ability of this strain (see above). 
Our model proposing that rifampicin can alter transcription specificity derives
further support from experiments reported by many others. Rifampicin may cause 
activation of promoters and read-through past terminators (Newman et al., 1982; 
Fukuda and Fujimori, 1983), and affect varied cellular processes (Buchstein and Hinkle, 
1982; Mirkin and Shmerling, 1982; Ito and Ohnishi, 1983; Polaczek and Ciesla, 1983). 
In addition, we have observed that rpoB240 mutation, in combination with different fit
mutations, leads to changes in the expression of a number of gene groups, including 
phage genomes and the lactose operon, and also alters the viability of strains in minimal
medium. These results will be published elsewhere.
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